Urine epigenomics: A promising path for bladder cancer diagnostics

Expert Review of Molecular Diagnostics

Volumn 12, Issue 5, 2012, Pages 429-432

  Sánchez Carbayo, Marta ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

Author keywords

bladder cancer; methylation; miRNAs; urine

Indexed keywords

BCG VACCINE; CARCINOGEN; CISPLATIN; DNA; MESSENGER RNA; MICRORNA;

BLADDER CANCER; BLADDER EPITHELIUM; CANCER CELL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CELL ASSAY; CPG ISLAND; CYSTOSCOPY; CYTOLOGY; DISEASE SURVEILLANCE; DNA METHYLATION; EPIGENETICS; FOLLOW UP; GENETIC RISK; GOLD STANDARD; HIGH THROUGHPUT SCREENING; HISTOPATHOLOGY; HUMAN; MARKER GENE; NON INVASIVE PROCEDURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; RNA METHYLATION; RNA STABILITY; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; URINALYSIS; URINE EPIGENOMICS; UROGENITAL TRACT CANCER;

EID: 84862542721     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.12.42     Document Type: Review

References (20)

1. Sánchez-Carbayo M. Hypermethylation in bladder cancer: biological pathways and translational applications. Tumour Biol. 33, 347-361 (2012)
2. Chan MW, Chan LW, Tang NL et al. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. Clin. Cancer Res. 8, 464-470 (2002) (Pubitemid 34193966)
3. Friedrich MG, Weisenberger DJ, Cheng JC et al. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin. Cancer Res. 10, 7457-7465 (2004) (Pubitemid 39557507)
4. Sathyanarayana UG, Maruyama R, Padar A et al. Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes. Cancer Res. 64, 1425-1430 (2004) (Pubitemid 38235612)
5. Hoque MO, Begum S, Topaloglu O et al. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J. Natl Cancer Inst. 98, 996-1004 (2006) (Pubitemid 44288164)
6. Yates DR, Rehman I, Meuth M et al. Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls. Oncogene 25, 1984-1988 (2006)
7. Urakami S, Shiina H, Enokida H et al. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin. Cancer Res. 12, 2109-2116 (2006)
8. Yu J, Zhu T, Wang Z et al. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin. Cancer Res. 13, 7296-7304 (2007)
9. Hoque MO, Begum S, Brait M et al. Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer. J. Urol. 179, 743-747 (2008)
10. Cebrian V, Alvarez M, Aleman A et al. Discovery of myopodin methylation in bladder cancer. J. Pathol. 216, 111-119 (2008)
11. Aleman A, Cebrian V, Alvarez M et al. Identification of PMF1 methylation in association with bladder cancer progression. Clin. Cancer Res. 14, 8236-8243 (2008)
12. Costa VL, Henrique R, Danielsen SA et al. Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples. Clin. Cancer Res. 16, 5842-5851 (2010)
13. Reinert T, Modin C, Castano FM et al. Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers. Clin. Cancer Res. 17, 5582-5592 (2011)
14. Serizawa RR, Ralfkiaer U, Dahl C et al. Custom-designed MLPA using multiple short synthetic probes: application to methylation analysis of five promoter CpG islands in tumor and urine specimens from patients with bladder cancer. J. Mol. Diagn. 12, 402-408 (2010)
15. Cabello MJ, Grau L, Franco N et al. Multiplexed methylation profiles of tumor suppressor genes in bladder cancer. J. Mol. Diagn. 13, 29-40 (2011)
16. Zuiverloon TC, Beukers W, van der Keur KA et al. A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine. BJU Int. 109(6), 941-948 (2012)
17. Hanke M, Hoefig K, Merz H et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol. Oncol. 28, 655-661 (2010)
18. Yamada Y, Enokida H, Kojima S et al. miR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci. 102, 522-529 (2011)
19. Wang G, Chan ES, Kwan BC et al. Expression of microRNAs in the urine of patients with bladder cancer. Clin. Genitourin. Cancer doi:10.1016/j.clgc.2012. 01.001 (2012) (Epub ahead of print)
20. Puerta-Gil P, García-Baquero R, Jia AY et al. miR-143, miR-222, and miR-452 are useful as tumor stratification and non-invasive diagnostic biomarkers for bladder cancer. Am. J. Pathol. 180(5), 1808-1815 (2012).